Accendra Health, Inc. ACH
NYSE
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -1.87% | -2.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.87% | -2.32% | |||
| Cost of Revenue | -2.68% | 0.02% | |||
| Gross Profit | -0.80% | -5.26% | |||
| SG&A Expenses | 2.42% | -4.57% | |||
| Depreciation & Amortization | -82.98% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.45% | -1.83% | |||
| Operating Income | 173.20% | -45.98% | |||
| Income Before Tax | 57.98% | -439.38% | |||
| Income Tax Expenses | -1,407.77% | 114.75% | |||
| Earnings from Continuing Operations | 79.83% | -1,277.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 77.88% | -1,277.09% | |||
| EBIT | 173.20% | -45.98% | |||
| EBITDA | -18.70% | 1.81% | |||
| EPS Basic | 77.95% | -1,272.81% | |||
| Normalized Basic EPS | 30.01% | -11.62% | |||
| EPS Diluted | 77.95% | -1,272.81% | |||
| Normalized Diluted EPS | 30.01% | -11.62% | |||
| Average Basic Shares Outstanding | 0.28% | 0.34% | |||
| Average Diluted Shares Outstanding | 0.28% | 0.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||